本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Catalyst Pharmaceutical Partners

22.76
-0.7000-2.98%
盘前23.170.4108+1.80%08:41 EDT
成交量:268.50万
成交额:5,956.42万
市值:27.76亿
市盈率:17.37
高:23.17
开:23.17
低:20.80
收:23.46
数据加载中...

公司资料

公司名字:
Catalyst Pharmaceutical Partners
交易所:
NASDAQ
成立时间:
2002
员工人数:
181
公司地址:
355 Alhambra Circle,Suite 801,Coral Gables,Florida,United States
邮编:
33134
电话:
传真:
- -
简介:
Catalyst Pharmaceuticals, Inc.于2006年7月在特拉华州注册成立。该公司是一家商业阶段、以患者为中心的生物制药公司,专注于为患有罕见和难以治疗的疾病的患者提供新的高质量药物的许可、开发和商业化。该公司利用协调一致的勤奋努力,寻找能够改善那些患有罕见或难以治疗的疾病的人的生活的疗法。

董事

名称
职位
Patrick J. McEnany
Chairman,President and CEO
Charles B. O'Keeffe
Lead Independent Director
David S. Tierney
Director
Donald A. Denkhaus
Director
Molly Harper
Director
Richard J. Daly
Director
Tamar Thompson
Director

股东

名称
职位
Steven R. Miller
Chief Operating Officer and Chief Scientific Officer
Alicia Grande
Vice President, Treasurer and Chief Financial Officer
Brian Elsbernd
Chief Compliance Officer and Chief Legal Officer
Gary Ingenito
Chief Medical and Regulatory Officer
Jeffrey Del Carmen
Chief Commercial Officer
Patrick J. McEnany
Chairman,President and CEO
Preethi Sundaram
Chief Strategy Officer